MICHELLE GORMAS: Open Payments
NPI 1144479148 · OKEMOS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$724 in 36 payments from 14 companies in 2025. Trend: 2023 $271 · 2024 $141 · 2025 $724
Food & beverage: $724
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 4 | $158 |
| Novo Nordisk Inc | 11 | $138 |
| Otsuka America Pharmaceutical, Inc. | 5 | $102 |
| Axsome Therapeutics, Inc. | 3 | $83 |
| Amgen Inc. | 2 | $40 |
| Exact Sciences Corporation | 2 | $37 |
| ABBVIE INC. | 2 | $30 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $24 |
| Lundbeck LLC | 1 | $23 |
| PFIZER INC. | 1 | $22 |
Products named: REXULTI, ZEPBOUND, Wegovy, Auvelity, Ozempic, EVENITY, MOUNJARO, VRAYLAR.
Industry payments across MI — which companies pay providers there.
